News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Niklason Laura E
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
4
| Niklason Laura E (President, CEO and Director) has filed a Form 4 on Humacyte, Inc.|
Txns:
| Exercised 114,420 options to buy
@ $1.19, valued at
$136.2k
|
|
| 08/21/2023 |
4
| Niklason Laura E (President, CEO and Director) has filed a Form 4 on Humacyte, Inc.|
Txns:
| Sold 570,174 shares
@ $3.68, valued at
$2.1M
Sold 626,979 shares
@ $3.57, valued at
$2.2M
Sold 602,443 shares
@ $3.39, valued at
$2M
|
|
| 06/16/2023 |
4
| Niklason Laura E (President, CEO and Director) has filed a Form 4 on Humacyte, Inc.|
Txns:
| Granted 8,500 options to buy
@ $3.35, valued at
$28.5k
|
|
| 06/16/2023 |
4
| Niklason Laura E (President, CEO and Director) has filed a Form 4 on Humacyte, Inc.|
Txns:
| Sold 500,000 shares
@ $3.1175, valued at
$1.6M
|
|
| 05/26/2023 |
SC 13D/A
| Niklason Laura E reports a 17.9% stake in HUMACYTE, INC. |
| 05/26/2023 |
4
| Niklason Laura E (President, CEO and Director) has filed a Form 4 on Humacyte, Inc.|
Txns:
| Sold 2,625,000 shares
@ $2.75, valued at
$7.2M
|
|
| 03/02/2023 |
4
| Niklason Laura E (President, CEO and Director) has filed a Form 4 on Humacyte, Inc.|
Txns:
| Exercised 100,000 options to buy
@ $1.19, valued at
$119k
|
|
| 12/19/2022 |
4
| Niklason Laura E (President, CEO and Director) has filed a Form 4 on Humacyte, Inc.|
Txns:
| Bought 10,000 shares
@ $2.54, valued at
$25.4k
|
|
| 12/19/2022 |
4
| Niklason Laura E (President, CEO and Director) has filed a Form 4 on Humacyte, Inc.|
Txns:
| Sold 239,538 shares
@ $2.53, valued at
$606k
|
|
| 12/15/2022 |
4
| Niklason Laura E (President, CEO and Director) has filed a Form 4 on Humacyte, Inc.|
Txns:
| Sold 330,000 shares
@ $2.84, valued at
$937.2k
Sold 276,304 shares
@ $2.76, valued at
$762.6k
Sold 93,426 shares
@ $2.63, valued at
$245.7k
|
|
| 12/12/2022 |
4
| Niklason Laura E (President, CEO and Director) has filed a Form 4 on Humacyte, Inc.|
Txns:
| Granted 444,500 options to buy
@ $3.07, valued at
$1.4M
|
|
| 09/19/2022 |
4
| Niklason Laura E (President, CEO and Director) has filed a Form 4 on Humacyte, Inc.|
Txns:
| Bought 2,000 shares
@ $4.14, valued at
$8.3k
|
|
| 09/19/2022 |
SC 13D/A
| Niklason Laura E reports a 21.3% stake in HUMACYTE, INC. |
| 09/19/2022 |
4
| Niklason Laura E (President, CEO and Director) has filed a Form 4 on Humacyte, Inc.|
Txns:
| Sold 1,522,500 shares
@ $4, valued at
$6.1M
|
|
| 06/13/2022 |
4
| Niklason Laura E (President, CEO and Director) has filed a Form 4 on Humacyte, Inc.|
Txns:
| Granted 8,500 options to buy
@ $4.34, valued at
$36.9k
|
|
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 08/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|